Expert Radar
Dr. William Zamboni, PharmD, PhD
Dr. William Zamboni, PharmD, PhD
Director, UNC Lineberger Comprehensive Cancer Center (Chapel Hill, NC)
Doctor of Pharmacy, University of Pittsburgh School of Pharmacy
Dr. William C. Zamboni has over 26 years of experience in the field of Pharmacotherapy and Experimental Therapeutics. He earned his BS in Pharmacy and his PharmD and his PhD in Pharmaceutical Sciences from the University of Pittsburgh. After completing his residency in Oncology Pharmacy residency at the National Institutes of Health, he went on to complete a research fellowship in Pharmaceutical Sciences at St. Jude Children's Research Hospital. Formerly, the expert served as the Clinical Assistant Professor in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, and as an Assistant Professor in the Department of Developmental Therapeutics at the University of Maryland Marlene and Stewart Greenebaum Cancer Center. Currently, he serves as a Professor in the Division of Pharmacotherapy and Experimental Therapeutics, and as the Director of UNC Advanced Translational Pharmacology and Analytical Chemistry (ATPAC) Lab and Recharge Center, UNC Lineberger Comprehensive Cancer Center at UNC Eshelman School of Pharmacy.
z*********@***.edu
(919) ***-****
Chapel Hill, North Carolina
Get a FREE Demo of Dr. William Zamboni, PharmD, PhD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
DISCLAIMER: Expert Institute operates independently and objectively as an expert witness data provider. This listing does not reflect or imply any existing relationship between the expert and Expert Institute. We do not employ, endorse, or maintain any affiliation with the experts listed. Information shown is automatically generated from public sources and may not be current or complete. For verified, in-depth expert data, please contact us to initiate a formal request.
Radar Metrics At A Glance
Expert Witness Activity
29
Plaintiff Cases
8
Defense Cases
12
Expert Challenges
4
Deposition Transcripts
Publications
189
Media & News
344
Social Media Mentions
Expert Witness Activity
Radar found 41 records
Case Name | Role | Filed Date |
|---|---|---|
Ansel, Eric Lee v. Walgreen, Co., et al. | Expert Witness | 2022-09-22 |
Maria Castore v. Pfizer, Inc., et al. | Expert Witness | 2022-01-12 |
Radar monitors both national and state court systems to track litigation activity and access court documents.
View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Education
Institution | Degree Type |
|---|---|
University of Pittsburgh School of Pharmacy | Doctor of Pharmacy |
University of Pittsburgh School of Pharmacy | Doctor of Philosophy |
University of Pittsburgh School of Pharmacy | Bachelor of Science |
Work History
Radar found 11 records
Title | Employer |
|---|---|
Director | UNC Lineberger Comprehensive Cancer Center (Chapel Hill, NC) |
Research Associate Professor | UNC School of Medicine (Chapel Hill, NC) |
Director | UNC Eshelman School of Pharmacy (Chapel Hill, NC) |
Director | UNC Eshelman School of Pharmacy (Chapel Hill, NC) |
Principal Investigator | UNC Eshelman School of Pharmacy (Chapel Hill, NC) |
Director | UNC Eshelman School of Pharmacy (Chapel Hill, NC) |
Co-Faculty Director | UNC Eshelman School of Pharmacy (Chapel Hill, NC) |
Professor | UNC Eshelman School of Pharmacy (Chapel Hill, NC) |
Chief Executive Officer | MediGLO, LLC |
Chief Scientific Officer | ChemoGLO, LLC |
Chief Scientific Officer | Glolytics, LLC |
Publications
Radar found 189 records
Title | Type |
|---|---|
Intestinal E. coli-produced yersiniabactin promotes profibrotic macrophages in Crohn's disease | Journal Article |
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma | Journal Article |
Development of LC-MS/MS methods affording identification and measurement of active metabolites in rat and dog plasma after oral dosing of a penta-ethyl ester prodrug of diethylenetriamine pentaacetic acid | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Media & News
Radar found 344 records
Title | Description |
|---|
Unlock Dr. William Zamboni, PharmD, PhD's full profile
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 3–5 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
